Decoding virtual clinical trials and simulation-guided procedures

Dr. Yiannis Chatzizisis, an internationally recognized interventional cardiologist, was at a crossroads. Two of his patients presented with significant blockages in their left main coronary artery, the heart’s biggest artery that is essential to its function. Dr. Chatzizisis could opt for a conventional stenting approach that fails in 30% of patients. Or he could leverage computational technology to assess infinite scenarios and obtain detailed insights into stent performance and technique optimization – all before deployment in each patient.

Tune in to hear how Dr. Chatzizisis performed the world’s first simulation-guided left main stenting procedure using artificial intelligence, computational simulations and extended reality. And, how he and his team utilize these technologies to advance “virtual clinical trials” to test the efficacy and safety of new drugs, medical devices or procedures.